These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 4110181

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Clearing and anti-platelet-aggregation effects of a heparinoid of natural origin].
    Marini U, Bastoni F, Gibelli A.
    Clin Ter; 1974 Oct 15; 71(1):13-31. PubMed ID: 4138995
    [No Abstract] [Full Text] [Related]

  • 8. [Controlled experimental study of the relations between fibrinolytic acitivity and anticoagulant activity in evaluation of activators of fibrinolysis].
    Cascone A, Lampugnani P.
    Minerva Med; 1969 Dec 12; 60(99 Suppl):5039-45. PubMed ID: 4188588
    [No Abstract] [Full Text] [Related]

  • 9. Preangioplasty fibrinolytic therapy using SP-54 including acute and subacute occlusions.
    Haapanen A, Leinonen A, Seppänen S.
    Ann Radiol (Paris); 1984 Dec 12; 27(4):340. PubMed ID: 6204575
    [No Abstract] [Full Text] [Related]

  • 10. Comparative investigations on the effect of nicotinic acid alone and in association with a synthetic, heparin-like sulfated polyanion on fibrinolysis, platelet aggregation and lipidic fractions.
    Turazza G, Spreafico PL, Frandoli G.
    Arzneimittelforschung; 1973 May 12; 23(5):654-7. PubMed ID: 4575777
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Study of the activity of a sulfomucopolysaccharide extractive on the blood-lipid and fibrinolytic pattern in atherosclerotic disease].
    Isidori A, Recchia O, Butti A.
    Minerva Med; 1967 Mar 07; 58(19):779-82. PubMed ID: 4164416
    [No Abstract] [Full Text] [Related]

  • 16. [Fibrinolytic therapy of arteriosclerosis. Influence on hemocoagulation of a total arterial wall extract for oral use].
    Guglielmi G, Barlattani M, Garbagnati N, Iaschi P, Ciavarelli F.
    Clin Ter; 1969 Sep 30; 50(6):527-36. PubMed ID: 5406050
    [No Abstract] [Full Text] [Related]

  • 17. Beta-benzal-butyric acid, a new anti-adhesive drug.
    Mannucci PM, Maggi CA, Gioventu M, Marchi E, Terruzzi AB.
    Acta Univ Carol Med Monogr; 1972 Sep 30; 53():409-12. PubMed ID: 4670746
    [No Abstract] [Full Text] [Related]

  • 18. Platelet-suppressive therapy in cardiovascular disease.
    Mehta J, Roy L.
    Cardiovasc Clin; 1984 Sep 30; 14(3):211-34. PubMed ID: 6722852
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Electroencephalographic and audiometric controls in presenile and senile arteriosclerotic subjects treated with an extractive sulfomucopolysaccharide complex with fibrinolytic action].
    Sfondrini E, Barberi G.
    Minerva Med; 1969 Dec 12; 60(99 Suppl):5082-6. PubMed ID: 4188593
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.